November 8, 2024 Psychiatric disorders vs. early neuropsychiatric symptoms of a neurodegenerative disease: What's a clinician to do? Presenter: Jennifer Gatchel, MD

Resources:
- International Society to Advance Alzheimer's Research and Treatment: 2022 Year in Review
- Ismail et al. (2017) The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Patients
- Ismail et al (2017) Psychosis in Alzheimer's Disease: Mechanisms, Genetics and Therapeutic Opportunities
- Johansson et al (2022) Development of Apathy, Anxiety, and Depression in Cognitively Impaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline
- Johansson et al (2021) Mild Behavioral Impairment and its Relation to Tau Pathology in Preclinical Alzheimer's Disease
- Johansson et al (2020) Apathy and Anxiety are Early Markers of Alzheimer's Disease
- d'Angremont et al (2023) Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Diseaes A Meta-Analysis
- Burling et al (2023) Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings fromHarvard Aging Brain Study
- Molano et al (2023) Cholinesterase Inhibitors and Psychiatric Symptoms in Alzheimer Disease and Parkinson Disease
- Mood Assessment Scale (GDS)
- Geriatric Anxiety Inventory (GAI) Journal Article
- Geriatric Anxiety Inventory (GAI) Assessment Tool
- Geriatric Depression Scale Website
- The Neuropsychiatric Inventory Questionnaire (NPI-Q): Backgrounds and Administration